Clinical Trial Update: Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail [Phase 2, Phase 3]

View source ↗

Summary

The document describes a Phase 2/3 clinical trial comparing extended-release naltrexone to extended-release buprenorphine for individuals leaving jail with opio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)
• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING